Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter: Presentation as hypercalciuria and nephrolithiasis

Amanda L. Tencza, Shoji Ichikawa, Anna Dang, David Kenagy, Edward McCarthy, Michael Econs, Michael A. Levine

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Context: Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a metabolic disorder due to homozygous loss-of-function mutations in the SLC34A3 gene encoding the renal type IIc sodium-phosphate cotransporter (NaPi-IIc). The typical presentation is severe rickets and hypophosphatemia, and hypercalciuria is often discovered later or overlooked. Objective: We sought to determine the genetic basis for severe hypercalciuria and nephrolithiasis/nephrocalcinosis in an adolescent male with elevated serum levels of calcitriol but normal serum levels of calcium and phosphorus. Design and Setting: We used PCR to analyze the SLC34A3 gene in the proband and members of his family. Results: The proband was a compound heterozygote for two SLC34A3 missense mutations, a novel c.544C→T in exon 6 that results in replacement of arginine at position 182 by tryptophan (R182W) and c.575C→T in exon 7 that results in replacement of serine at position 192 by leucine (S192L). The R182W and S192L alleles were inherited from the mother and father, respectively, both of whom had hypercalciuria. A clinically unaffected brother was heterozygous for S192L. Conclusion: We report a novel mutation in the SLC34A3 gene in a patient with an unusual presentation of HHRH. This report emphasizes that moderate and severe hypercalciuria can be manifestations of heterozygous or homozygous loss-of-function mutations in the SLC34A3 gene, respectively, providing further evidence for a gene dosage effect in determining the phenotype. HHRH may be an underdiagnosed condition that can masquerade as idiopathic hypercalciuria or osteopenia.

Original languageEnglish
Pages (from-to)4433-4438
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume94
Issue number11
DOIs
StatePublished - Nov 2009

Fingerprint

Sodium-Phosphate Cotransporter Proteins
Hypophosphatemic Rickets
Hypercalciuria
Nephrolithiasis
Genes
Mutation
Exons
Gene encoding
Calcitriol
Nephrocalcinosis
Hypophosphatemia
Rickets
Leucine
Tryptophan
Gene Dosage
Phosphorus
Serine
Metabolic Bone Diseases
Arginine
Missense Mutation

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter : Presentation as hypercalciuria and nephrolithiasis. / Tencza, Amanda L.; Ichikawa, Shoji; Dang, Anna; Kenagy, David; McCarthy, Edward; Econs, Michael; Levine, Michael A.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 94, No. 11, 11.2009, p. 4433-4438.

Research output: Contribution to journalArticle

Tencza, Amanda L. ; Ichikawa, Shoji ; Dang, Anna ; Kenagy, David ; McCarthy, Edward ; Econs, Michael ; Levine, Michael A. / Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter : Presentation as hypercalciuria and nephrolithiasis. In: Journal of Clinical Endocrinology and Metabolism. 2009 ; Vol. 94, No. 11. pp. 4433-4438.
@article{75855eb12da44558b90587a71c61735b,
title = "Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter: Presentation as hypercalciuria and nephrolithiasis",
abstract = "Context: Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a metabolic disorder due to homozygous loss-of-function mutations in the SLC34A3 gene encoding the renal type IIc sodium-phosphate cotransporter (NaPi-IIc). The typical presentation is severe rickets and hypophosphatemia, and hypercalciuria is often discovered later or overlooked. Objective: We sought to determine the genetic basis for severe hypercalciuria and nephrolithiasis/nephrocalcinosis in an adolescent male with elevated serum levels of calcitriol but normal serum levels of calcium and phosphorus. Design and Setting: We used PCR to analyze the SLC34A3 gene in the proband and members of his family. Results: The proband was a compound heterozygote for two SLC34A3 missense mutations, a novel c.544C→T in exon 6 that results in replacement of arginine at position 182 by tryptophan (R182W) and c.575C→T in exon 7 that results in replacement of serine at position 192 by leucine (S192L). The R182W and S192L alleles were inherited from the mother and father, respectively, both of whom had hypercalciuria. A clinically unaffected brother was heterozygous for S192L. Conclusion: We report a novel mutation in the SLC34A3 gene in a patient with an unusual presentation of HHRH. This report emphasizes that moderate and severe hypercalciuria can be manifestations of heterozygous or homozygous loss-of-function mutations in the SLC34A3 gene, respectively, providing further evidence for a gene dosage effect in determining the phenotype. HHRH may be an underdiagnosed condition that can masquerade as idiopathic hypercalciuria or osteopenia.",
author = "Tencza, {Amanda L.} and Shoji Ichikawa and Anna Dang and David Kenagy and Edward McCarthy and Michael Econs and Levine, {Michael A.}",
year = "2009",
month = "11",
doi = "10.1210/jc.2009-1535",
language = "English",
volume = "94",
pages = "4433--4438",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter

T2 - Presentation as hypercalciuria and nephrolithiasis

AU - Tencza, Amanda L.

AU - Ichikawa, Shoji

AU - Dang, Anna

AU - Kenagy, David

AU - McCarthy, Edward

AU - Econs, Michael

AU - Levine, Michael A.

PY - 2009/11

Y1 - 2009/11

N2 - Context: Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a metabolic disorder due to homozygous loss-of-function mutations in the SLC34A3 gene encoding the renal type IIc sodium-phosphate cotransporter (NaPi-IIc). The typical presentation is severe rickets and hypophosphatemia, and hypercalciuria is often discovered later or overlooked. Objective: We sought to determine the genetic basis for severe hypercalciuria and nephrolithiasis/nephrocalcinosis in an adolescent male with elevated serum levels of calcitriol but normal serum levels of calcium and phosphorus. Design and Setting: We used PCR to analyze the SLC34A3 gene in the proband and members of his family. Results: The proband was a compound heterozygote for two SLC34A3 missense mutations, a novel c.544C→T in exon 6 that results in replacement of arginine at position 182 by tryptophan (R182W) and c.575C→T in exon 7 that results in replacement of serine at position 192 by leucine (S192L). The R182W and S192L alleles were inherited from the mother and father, respectively, both of whom had hypercalciuria. A clinically unaffected brother was heterozygous for S192L. Conclusion: We report a novel mutation in the SLC34A3 gene in a patient with an unusual presentation of HHRH. This report emphasizes that moderate and severe hypercalciuria can be manifestations of heterozygous or homozygous loss-of-function mutations in the SLC34A3 gene, respectively, providing further evidence for a gene dosage effect in determining the phenotype. HHRH may be an underdiagnosed condition that can masquerade as idiopathic hypercalciuria or osteopenia.

AB - Context: Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a metabolic disorder due to homozygous loss-of-function mutations in the SLC34A3 gene encoding the renal type IIc sodium-phosphate cotransporter (NaPi-IIc). The typical presentation is severe rickets and hypophosphatemia, and hypercalciuria is often discovered later or overlooked. Objective: We sought to determine the genetic basis for severe hypercalciuria and nephrolithiasis/nephrocalcinosis in an adolescent male with elevated serum levels of calcitriol but normal serum levels of calcium and phosphorus. Design and Setting: We used PCR to analyze the SLC34A3 gene in the proband and members of his family. Results: The proband was a compound heterozygote for two SLC34A3 missense mutations, a novel c.544C→T in exon 6 that results in replacement of arginine at position 182 by tryptophan (R182W) and c.575C→T in exon 7 that results in replacement of serine at position 192 by leucine (S192L). The R182W and S192L alleles were inherited from the mother and father, respectively, both of whom had hypercalciuria. A clinically unaffected brother was heterozygous for S192L. Conclusion: We report a novel mutation in the SLC34A3 gene in a patient with an unusual presentation of HHRH. This report emphasizes that moderate and severe hypercalciuria can be manifestations of heterozygous or homozygous loss-of-function mutations in the SLC34A3 gene, respectively, providing further evidence for a gene dosage effect in determining the phenotype. HHRH may be an underdiagnosed condition that can masquerade as idiopathic hypercalciuria or osteopenia.

UR - http://www.scopus.com/inward/record.url?scp=70449135211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449135211&partnerID=8YFLogxK

U2 - 10.1210/jc.2009-1535

DO - 10.1210/jc.2009-1535

M3 - Article

C2 - 19820004

AN - SCOPUS:70449135211

VL - 94

SP - 4433

EP - 4438

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 11

ER -